Company :: Vision

Our Vision

picture of doctor with PDAABL's vision is to help improve the quality of care for people living with HIV by assisting their healthcare providers with HIV specific therapeutic decision support and medical record systems that use the latest medical research and expertise in the field.

We help clinicians make quality therapeutic decisions that directly impact a patient's life.

We invite you to join us in the mission to help improve the quality of care for HIV patients. Together, we can increase the number of patients who have access to antiretroviral therapies and the necessary tools and training for their use.

About ABL

picture of doctor at computerAdvanced Biological Laboratories (ABL) S.A. is a biotech company that was created in 2000 as a spin-off from the European academic research center (CRP-Santé, Luxembourg). Our expertise is in infectious diseases and more specifically in the molecular biology and clinical outcome predictors of HIV, hepatitis and HPV viruses.

The company has developed a strong focus on HIV drug resistance, mainly on algorithm-based genotype interpretation systems, the management of sequence and complex integrated clinico-virological databases, and on more advanced genetic analysis tools such as virus subtype characterization.

ABL has participated in several research and development projects and has developed a customized web-based data management system for the EU-sponsored research project called SPREAD (Strategy to Control Spread of HIV Drug Resistance).

ABL is a full partner and workpackage leader in the writing and the submission of excellence projects within the 6th Framework Programme (pending).